IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentation

Journal of Immunology

Volumn 192, Issue 6, 2014, Pages 2634-2642

  Morandi, Fabio ^a   Di Carlo, Emma ^b   Ferrone, Soldano ^c   Petretto, Andrea ^a   Pistoia, Vito ^a   Airoldi, Irma ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD59 ANTIGEN; CD8 ANTIGEN; CELL PROTEIN; CHEMOKINE RECEPTOR CXCR4; CYTOKINE RECEPTOR; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 27; INTERLEUKIN 27 RECEPTOR; PROTEIN LM10; PROTEIN LM7; TAPASIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL SYNAPSE; IMMUNOREACTIVITY; IMMUNOREGULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LYMPH NODE; LYMPHOID ORGAN; MACROPHAGE; MALE; MYELOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION;

ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD11C; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-27; LYMPH NODES; MACROPHAGES; MICROSCOPY, CONFOCAL; MYELOID CELLS; RECEPTORS, INTERLEUKIN; T-LYMPHOCYTES;

EID: 84897564889     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302656     Document Type: Article

References (34)

1. Pflanz, S., J. C. Timans, J. Cheung, R. Rosales, H. Kanzler, J. Gilbert, L. Hibbert, T. Churakova, M. Travis, E. Vaisberg, et al. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16: 779-790.
2. Trinchieri, G., S. Pflanz, and R. A. Kastelein. 2003. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19: 641-644.
3. Chen, Q., N. Ghilardi, H. Wang, T. Baker, M. H. Xie, A. Gurney, I. S. Grewal, and F. J. de Sauvage. 2000. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407: 916-920.
4. Pflanz, S., L. Hibbert, J. Mattson, R. Rosales, E. Vaisberg, J. F. Bazan, J. H. Phillips, T. K. McClanahan, R. de Waal Malefyt, and R. A. Kastelein. 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172: 2225-2231.
5. Laroni, A., R. Gandhi, V. Beynon, and H. L. Weiner. 2011. IL-27 imparts immunoregulatory function to human NK cell subsets. PLoS ONE 6: e26173.
6. Boumendjel, A., L. Tawk, Rde. W. Malefijt, V. Boulay, H. Yssel, and J. Péne. 2006. IL-27 induces the production of IgG1 by human B cells. Eur. Cytokine Netw. 17: 281-289.
7. Cocco, C., F. Morandi, and I. Airoldi. 2011. Interleukin-27 and interleukin-23 modulate human plasmacell functions. J. Leukoc. Biol. 89: 729-734.
8. Morandi, F., I. Prigione, and I. Airoldi. 2012. Human TCRgd+ T cells represent a novel target for IL-27 activity. Eur. J. Immunol. 42: 1547-1552.
9. Karakhanova, S., T. Bedke, A. H. Enk, and K. Mahnke. 2011. IL-27 renders DC immunosuppressive by induction of B7-H1. J. Leukoc. Biol. 89: 837-845.
10. Batten, M., and N. Ghilardi. 2007. The biology and therapeutic potential of interleukin 27. J. Mol. Med. 85: 661-672.
11. Villarino, A., L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, R. A. Kastelein, C. Saris, and C. A. Hunter. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19: 645-655.
12. Villarino, A. V., J. S. Stumhofer, C. J. Saris, R. A. Kastelein, F. J. de Sauvage, and C. A. Hunter. 2006. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 176: 237-247.
13. Yoshimura, T., A. Takeda, S. Hamano, Y. Miyazaki, I. Kinjyo, T. Ishibashi, A. Yoshimura, and H. Yoshida. 2006. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J. Immunol. 177: 5377-5385.
14. Batten, M., N. M. Kljavin, J. Li, M. J. Walter, F. J. de Sauvage, and N. Ghilardi. 2008. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 180: 2752-2756.
15. Awasthi, A., Y. Carrier, J. P. Peron, E. Bettelli, M. Kamanaka, R. A. Flavell, V. K. Kuchroo, M. Oukka, and H. L. Weiner. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8: 1380-1389.
16. Hirahara, K., K. Ghoreschi, X. P. Yang, H. Takahashi, A. Laurence, G. Vahedi, G. Sciumè, A. O. Hall, C. D. Dupont, L. M. Francisco, et al. 2012. Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity 36: 1017-1030.
17. Ogino, T., X. Wang, and S. Ferrone. 2003. Modified flow cytometry and cell-ELISA methodology to detect HLA class I antigen processing machinery components in cytoplasm and endoplasmic reticulum. J. Immunol. Methods 278: 33-44.
18. Corcione, A., N. Arduino, E. Ferretti, L. Raffaghello, S. Roncella, D. Rossi, F. Fedeli, L. Ottonello, L. Trentin, F. Dallegri, et al. 2004. CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells. Clin. Cancer Res. 10: 964-971.
19. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179: 1109-1118.
20. Wojno, E. D., N. Hosken, J. S. Stumhofer, A. C. O'Hara, E. Mauldin, Q. Fang, L. A. Turka, S. D. Levin, and C. A. Hunter. 2011. A role for IL-27 in limiting T regulatory cell populations. J. Immunol. 187: 266-273.
21. Yang, X. O., R. Nurieva, G. J. Martinez, H. S. Kang, Y. Chung, B. P. Pappu, B. Shah, S. H. Chang, K. S. Schluns, S. S. Watowich, et al. 2008. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29: 44-56.
22. Murugaiyan, G., A. Mittal, R. Lopez-Diego, L. M. Maier, D. E. Anderson, and H. L. Weiner. 2009. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J. Immunol. 183: 2435-2443.
23. Stumhofer, J. S., and C. A. Hunter. 2008. Advances in understanding the antiinflammatory properties of IL-27. Immunol. Lett. 117: 123-130.
24. Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5: 521-531.
25. Wang, S., Y. Miyazaki, Y. Shinozaki, and H. Yoshida. 2007. Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1 (IL-27R) deficiency. J. Immunol. 179: 6421-6428.
26. Yen, J. H., W. Kong, and D. Ganea. 2010. IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. J. Immunol. 184: 3478-3486.
27. Braun, A., T. Worbs, G. L. Moschovakis, S. Halle, K. Hoffmann, J. Bölter, A. Münk, and R. Förster. 2011. Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat. Immunol. 12: 879-887.
28. Bandoh, N., T. Ogino, H. S. Cho, S. Y. Hur, J. Shen, X. Wang, S. Kato, N. Miyokawa, Y. Harabuchi, and S. Ferrone. 2005. Development and characterization of human constitutive proteasome and immunoproteasome subunitspecific monoclonal antibodies. Tissue Antigens 66: 185-194.
29. Ogino, T., X. Wang, S. Kato, N. Miyokawa, Y. Harabuchi, and S. Ferrone. 2003. Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining. Tissue Antigens 62: 385-393.
30. Batten, M., J. Li, S. Yi, N. M. Kljavin, D. M. Danilenko, S. Lucas, J. Lee, F. J. de Sauvage, and N. Ghilardi. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7: 929-936.
31. Hamano, S., K. Himeno, Y. Miyazaki, K. Ishii, A. Yamanaka, A. Takeda, M. Zhang, H. Hisaeda, T. W. Mak, A. Yoshimura, and H. Yoshida. 2003. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19: 657-667.
32. Diveu, C., M. J. McGeachy, K. Boniface, J. S. Stumhofer, M. Sathe, B. Joyce-Shaikh, Y. Chen, C. M. Tato, T. K. McClanahan, R. de Waal Malefyt, et al. 2009. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol. 182: 5748-5756.
33. Zhu, C., R. Zhang, L. Liu, S. T. Rasool, Y. Mu, W. Sun, Q. Hao, F. Liu, Y. Zhu, and J. Wu. 2009. Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro. Clin. Immunol. 131: 92-97.
34. Shibata, S., Y. Tada, N. Kanda, K. Nashiro, M. Kamata, M. Karakawa, T. Miyagaki, H. Kai, H. Saeki, Y. Shirakata, et al. 2010. Possible roles of IL-27 in the pathogenesis of psoriasis. J. Invest. Dermatol. 130: 1034-1039.